Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma

OBJECTIVE: Oncolytic virotherapy is a promising alternative to conventional treatment, yet limited viral replication and immune-negative feedback are the major hurdles to effective viro-immunotherapy. METHODS: In this study, we found that use of an adjuvant of embelin, a small molecular inhibitor of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Wu, Yi, Yang, Chen, Zhao, Guanan, Liu, Yonghua, Cheng, Gang, Wang, Shibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034962/
https://www.ncbi.nlm.nih.gov/pubmed/32110041
http://dx.doi.org/10.2147/OTT.S209312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034962/
https://www.ncbi.nlm.nih.gov/pubmed/32110041
http://dx.doi.org/10.2147/OTT.S209312

Ejemplares similares